Net Cash Provided by (Used in) Operating Activities |
10.7M |
USD |
+485% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
50K |
USD |
-98.3% |
Q2 2022 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
-34K |
USD |
+15% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
20M |
shares |
0% |
Q3 2024 |
Q2 2025 |
Common Stock, Shares, Issued |
5.29M |
shares |
+0.31% |
Q3 2024 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q3 2024 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
10.7M |
USD |
+497% |
Q2 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
40.6M |
USD |
+143% |
Q3 2024 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
16K |
USD |
-60% |
Q2 2022 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
989K |
USD |
+16.1% |
Q1 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
14.5M |
USD |
-11.9% |
Q1 2024 |
FY 2024 |
Operating Lease, Liability |
69K |
USD |
-27.4% |
Q1 2024 |
FY 2024 |
Depreciation |
48K |
USD |
+50% |
Q2 2024 |
Q1 2025 |
Payments to Acquire Property, Plant, and Equipment |
34K |
USD |
-15% |
Q2 2024 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
11.2M |
USD |
-54% |
Q3 2024 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year Two |
29K |
USD |
+7.41% |
Q1 2024 |
FY 2024 |
Lessee, Operating Lease, Liability, to be Paid, Year One |
27K |
USD |
+3.85% |
Q1 2024 |
FY 2024 |
Operating Lease, Weighted Average Discount Rate, Percent |
0.06 |
pure |
0% |
Q1 2024 |
FY 2024 |
Deferred Income Tax Expense (Benefit) |
980K |
USD |
+54.1% |
Q2 2024 |
Q1 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year Three |
9K |
USD |
-69% |
Q1 2024 |
FY 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q1 2024 |
FY 2024 |
Current State and Local Tax Expense (Benefit) |
3.01M |
USD |
|
Q4 2022 |
Q3 2023 |
Current Federal Tax Expense (Benefit) |
13.1M |
USD |
|
Q4 2022 |
Q3 2023 |